Liraglutide Injection shortage
Current 11 presentations · 4 manufacturers · first FDA posting Jul 18, 2023 · last update Oct 14, 2026
Manufacturers: Hikma Pharmaceuticals USA, Inc., Meitheal Pharmaceuticals, Inc., Novo Nordisk, Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Delay in shipping of the drug; Discontinuation of the manufacture of the drug
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted Jul 18, 2023 Updated Oct 14, 2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Posted Jul 18, 2023 Updated Oct 14, 2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted Jul 18, 2023 Updated Aug 27, 2026 | |
| Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted Jul 18, 2023 Updated Aug 27, 2026 | |
| Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | Current Limited Availability |
Discontinuation of the manufacture of the drug | Product will be available until discontinuation in January 2027 | Posted Jul 18, 2023 Updated Sep 22, 2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12) | Novo Nordisk, Inc. | Current Limited Availability |
Delay in shipping of the drug | Estimated shortage duration: TBD | Posted Jul 18, 2023 Updated Sep 22, 2026 |
| Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13) | Novo Nordisk, Inc. | Current Limited Availability |
Delay in shipping of the drug | Estimated shortage duration: TBD | Posted Jul 18, 2023 Updated Sep 22, 2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20) | Novo Nordisk, Inc. | Current Available |
— | Distributed by Teva | Posted Jul 18, 2023 Updated Sep 22, 2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22) | Novo Nordisk, Inc. | Current Available |
— | Distributed by Teva | Posted Jul 18, 2023 Updated Sep 22, 2026 |
| Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15) | Novo Nordisk, Inc. | To Be Discontinued | — | Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug | Posted Aug 25, 2026 Updated Aug 25, 2026 Discontinued Aug 25, 2026 |
| Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 14, 2026 Updated May 14, 2026 Discontinued May 14, 2026 |